Lunan Pharmaceutical: Build the world's largest orlistat production base
"As part of the health industry, pharmaceutical companies cannot produce drugs while destroying the environment, and cannot exchange environmental protection for a competitive advantage. On the road to environmental protection, we are willing to survive with broken arms and use green development for long-term survival." Lunan Pharmaceuticals Said Zhang Guimin, party secretary, chairman and general manager of the group. Entering Lunan Pharmaceutical Group, you can understand more deeply: environmental protection is the bottom line of Lunan Pharmaceutical's development, and green is the background color of Lunan Pharmaceutical's development.
Look at Lunan Pharmaceutical
On "6.18" e-commerce day, JD Lunan Shuerjia's official Tmall flagship store Orlistat (Shuerjia) ranked first in sales of similar products, with more than 2.6 million user reviews; Tmall Lunan's official flagship store has a very high praise rate , The "non-chemical synthesis" of the product introduction is particularly eye-catching.
On June 20th, the commissioning ceremony of the Lunan Pharmaceutical Group Orlistat Industrialization Project was held at the Orlistat Industrialization Base. "China's Shuerjia, the world's Orlistat", Lunan Pharmaceutical Group Party Secretary, Chairman and General Manager Zhang Guimin solemnly put forward at the ceremony.
It is understood that orlistat is an OTC weight loss drug approved by the FDA, EMA and CFDA. Its safety is recognized worldwide and highly conforms to Lunan Pharmaceutical’s guiding ideology of "preventive treatment". Lunan Pharmaceutical uses it as a force for transformation and upgrading. point.
In March 2019, the Lunan Pharmaceutical Orlistat project won the first prize of Shandong Science and Technology Progress Award. Lunan Pharmaceutical Orlistat uses natural biological fermentation technology, using high-quality soybeans, glucose and other natural raw materials as biological fermentation raw materials. After dozens of days of high temperature fermentation, the highest raw material purity can reach 99.9%, which is different from the current chemical products on the market. Other synthetic orlistat products.
"Orlistat can be produced by chemical synthesis, but it is certainly not as environmentally friendly and greener as bio-fermentation." Lunan Pharmaceutical General Manager Assistant Bai Xuedong said, as a bio-fermentation project under the company's full automatic control, Lunan Pharmaceutical Orlistat has set a plan of "advanced development concept, scientific planning and layout, and high-standard project construction" since the establishment of the project. With a total investment of 600 million yuan, the project will become the world's largest production base for Orlistat.
Source pollution control, top-level design. Lunan Pharmaceutical insists on incorporating environmental protection into the top-level design of the company's development starting from the establishment of scientific research projects, and projects that are not environmentally friendly are resolutely not approved. For projects that have already produced economic benefits but will cause greater pollution, Lunan Pharmaceuticals has also taken the initiative to shut down. It has successively eliminated the project with an annual output of 1,000 tons of erythromycin sulfate and an annual output of 2,000 tons of 7-ADCA pharmaceutical intermediates. The project, the project with an annual output of 130 tons of 4-AA pharmaceutical intermediates-these capacity projects have an annual output value of nearly 3 billion yuan. Instead, innovative projects such as a series of bioengineering drug industrialization projects, a series of anti-tumor drug industrialization projects, orlistat industrialization projects, and modern Chinese medicine industrialization projects will produce Shouhui laxative capsules and orlistat , Jingfang Granules and other excellent products, which greatly meet the health needs of the people.
In Zhang Guimin's plan, the company's project layout has an "addition, subtraction, multiplication and division". Among them, the key to doing a good job of "dividing" is to reduce pollution through scientific and technological means, and do a good job in harmonious development and green development. This requires proactive implementation of all aspects of environmental protection responsibilities, putting "source prevention" in front of "end treatment", and transforming the sense of responsibility into practical actions.
Lunan Pharmaceutical is already a national innovative enterprise and a key high-tech enterprise of the National Torch Program. Established a circular economy technology research and development platform, and formed a professional environmental protection research team. Starting from the establishment of scientific research projects, environmental protection researchers are equipped to strengthen recycling, and make full use of every raw material to minimize the impact on the environment. , To create an "eco-environmental protection" model for the development of the pharmaceutical industry, and strive to be a benchmark for green development.
Looking for chemical products? Let suppliers reach out to you!
2026-07-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
ICIS Global No.58: ECHEMI Again Ranks Among the World’s Chemical Distributors
-
Supporting Each Other | ECHEMI Employees Voluntarily Raise Funds for Flood Relief in Southern Thailand
-
International Workers' Day Holiday Notice and Service Arrangement
-
China’s API Export Shift Takes Center Stage at API China 2026
-
New Location, New Horizon: ECHEMI Thailand Branch Embarks on a New Chapter
-
Notice of 2026 Chinese New Year Holiday
-
Address Change Declaration(ECHEMI SPECIALTIES)
Recommend Reading
-
Sinopec H1 Net Profit Plunges 44 Percent to 21.6 Billion Yuan Despite Output Growth Chemical Margins Remain Under Pressure
-
Braskem to Expand Ethylene and Polyethylene Production Capacity
-
Ashland Q3 Sales Drop 15 Percent but EBITDA Margin Holds at 24.4 Percent Self-Help Actions Boost Outlook
-
Sodium Alginate: Properties, Uses, and Benefits
-
Covestro Q2 Sales Down 8.4 Percent EBITDA Drops to €270 Million Outlook Cut Amid Tariff Shock and Price Squeeze